Applied Therapeutics Inc. (APLT) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 332 transactions totaling $46.2M, demonstrating a bearish sentiment with -$10.4M in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 57,111 shares valued at $0.
No significant insider buying has been recorded for APLT in the recent period.
No significant insider selling has been recorded for APLT in the recent period.
Based on recent SEC filings, insider sentiment for APLT is bearish with an Insider Alignment Score of 39/100 and a net flow of -$10.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Applied Therapeutics Inc. (APLT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading APLT stock, having executed 332 transactions in the past 90 days. The most active insider is Shoshana Shendelman (Executive), who has made 54 transactions totaling $16.8M.
Get notified when executives and directors at APLT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Chinoporos Constantine | See Remarks | Tender | 57,111 | $N/A | $0 | |
| Feb 3, 2026 | Chinoporos Constantine | See Remarks | Disposition | 1,000,000 | $N/A | $0 | |
| Feb 3, 2026 | Dale Hooks Corwin | Chief Commercial Officer | Tender | 5,753 | $N/A | $0 | |
| Feb 3, 2026 | Dale Hooks Corwin | Chief Commercial Officer | Disposition | 862,500 | $N/A | $0 | |
| Jan 1, 2026 | D. Funtleyder Leslie | Executive | Award | 150,000 | $N/A | $0 | |
| Dec 19, 2025 | Chinoporos Constantine | See Remarks | Award | 437,500 | $N/A | $0 | |
| Dec 19, 2025 | Dale Hooks Corwin | Chief Commercial Officer | Award | 312,500 | $N/A | $0 | |
| Dec 16, 2025 | J. Kanter Stacy | Executive | Sale | 43,000 | $0.11 | $4.7K | |
| Oct 1, 2025 | D. Funtleyder Leslie | Executive | Award | 150,000 | $N/A | $0 | |
| Jul 1, 2025 | D. Funtleyder Leslie | Executive | Award | 150,000 | $N/A | $0 | |
| Jun 9, 2025 | D. Funtleyder Leslie | Executive | Award | 150,000 | $N/A | $0 | |
| Aug 22, 2024 | Perfetti Riccardo | Executive | Sale | 22,681 | $5.83 | $132.2K | |
| Aug 22, 2024 | D. Funtleyder Leslie | Executive | Sale | 13,530 | $5.83 | $78.9K | |
| Aug 14, 2024 | Shendelman Shoshana | Executive | Sale | 119,591 | $5.93 | $709.2K | Large |
| Aug 13, 2024 | Shendelman Shoshana | Executive | Sale | 357,423 | $6.18 | $2.2M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 158 | $28.3M | 58.4% |
Purchase(P) | 18 | $17.9M | 37.0% |
Exercise(M) | 80 | $2.2M | 4.6% |
Tender(U) | 2 | $0 | 0.0% |
Disposition(D) | 2 | $0 | 0.0% |
Award(A) | 43 | $0 | 0.0% |
Gift(G) | 12 | $0 | 0.0% |
Other(J) | 10 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insider selling pressure at Applied Therapeutics Inc. has increased, with 16 insiders executing 332 transactions across all time. Total sales of $28.3M significantly outpace purchases of $17.9M, resulting in a net outflow of $10.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.